SCHEMBL360853

SCHEMBL360853

CC[C@H](C)[C@H](N)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1676981 1.00
SCHEMBL5056747 1.00
SCHEMBL1394505 1.00
SCHEMBL6372815 1.00
SCHEMBL4044077 1.00
SCHEMBL3213745 0.76
SCHEMBL9145456 0.74
SCHEMBL5798207 0.72
SCHEMBL3667167 0.72
SCHEMBL270306 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3921319-B1 IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST BEIGENE LTD (KY) 2024-03-06 EP claimed
US-20230167117-A1 IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST BEONE MEDICINES I GMBH (CH) 2023-06-01 US claimed
CN-113423708-A Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR7 agonists 百济神州有限公司 2021-09-21 CN claimed
CN-103012336-A Water-soluble amino-acid ester derivative of andrographolide and dehydroandrographolide BEIJING MEIBEITA PHARMACEUTICAL RES CO LTD 2013-04-03 CN claimed
CN-102049048-A Method of treatment or prophylaxis SPINIFEX PHARM PTY LTD 2011-05-11 CN claimed
CN-101812105-A Cytarabine 5'-O-amino-acid ester, salts thereof and preparation method thereof UNIV SHENYANG PHARMACEUTICAL 2010-08-25 CN claimed
US-20100056522-A1 INTRAOCULAR PRESSURE-LOWERING AGENT COMPRISING COMPOUND HAVING HISTONE DEACETYLASE INHIBITOR EFFECT AS ACTIVE INGREDIENT SANTEN PHARMACEUTICAL CO., LTD. (JP) 2010-03-04 US claimed
CN-101443001-A Methods of treating or preventing inflammatory pain UNIV QUEENSLAND (AU) 2009-05-27 CN claimed
CN-101376651-A Water-soluble amino acid ester derivatives of andrographolide and dehydroandrographolide BEIJING MEIBEITA DRUG RES CO L (CN) 2009-03-04 CN claimed
CN-101374551-A Novel glycolipid adjuvant compositions PFIZER PROD INC (US) 2009-02-25 CN claimed
CN-1500800-A Nucleoside analogs as antiviral agents for retroviral reverse transcriptase and DNA polymerase inhibitors ά 2004-06-02 CN claimed
CN-1113874-C Benzocycloalkylazolethione derivatives SYNTEX INC (US) 2003-07-09 CN claimed
US-20020065230-A1 Protease inhibitors SMITHKLINE BEECHAM CORPORATION 2002-05-30 US claimed
EP-0683792-B1 LHRH ANTAGONISTS HAVING MODIFIED AMINOACYL RESIDUES AT POSTIONS 5 AND 6 ABBOTT LAB (US) 2001-09-26 EP claimed
CN-1275983-A Nucleoside analogues, these compounds as antiviral agents comprising inhibitors of the reverse transcriptase and DNA polymerase of retroviruses of Hepatitis B Virus (HBV) MEDIVIR AB (SE) 2000-12-06 CN claimed
CN-1151735-A Benzocycloalkylazolethione derivatives SYNTEX INC (US) 1997-06-11 CN claimed
JP-H08505611-A 1996-06-18 JP claimed
CN-1104209-A 2,4-diamino-3-hydroxycarboxylic acid derivatives SANDOZ LTD (CH) 1995-06-28 CN claimed
EP-0296122-B1 CYCLOSPORINS AND THEIR USE AS PHARMACEUTICALS SANDOZ AG (CH) 1993-09-29 EP claimed
EP-0296122-A2 Cyclosporins and their use as pharmaceuticals SANDOZ AG (CH) 1988-12-21 EP claimed